FTO is shown to be abnormally regulated in t(11q23)/MLL-rearranged, t(15;17)/PML-RARA, FLT3-ITD, and/or NPM1-mutated AML phenotypes. This evidence concerns the gene RARA and acute myeloid leukemia.